Cardinal Health was awarded a $750,000 contract by FDA to implement an 18-month real world evidence study as part of the agency’s efforts to advance the applicability of RWE in regulatory decision-making.
To access this subscriber-only content please log in or renew your subscription.
Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.
Login Subscribe
Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.
Login Subscribe